DDIT4
DDIT4 (DNA damage inducible transcript 4, also known as REDD-1, REDD1, RTP801 and Dig2) is a stress-responsive protein that inhibits mTORC1 activity. Through this action it regulates cell growth, proliferation and survival in response to energy status, hypoxia and DNA damage. Browse Assay Genie's current range of DDIT4 research reagents below, or read on for the biology behind the target.
DDIT4 regulates cell growth, proliferation and survival by inhibiting the mammalian target of rapamycin complex 1 (mTORC1). This inhibition is mediated by a pathway involving DDIT4/REDD1, AKT1, the TSC1-TSC2 complex and the GTPase RHEB. The protein has an important role in responses to cellular energy levels and cellular stress, including hypoxia and DNA damage. Through its effect on mTORC1 activity, DDIT4 also regulates p53/TP53-mediated apoptosis after DNA damage.
The role of DDIT4 in hypoxia depends on cell type: it mediates mTORC1 inhibition in fibroblasts and thymocytes, but not in hepatocytes. It is also required for mTORC1-mediated defence against viral protein synthesis and virus replication. In the nervous system, DDIT4 inhibits NGF-driven neuronal differentiation and neurite outgrowth via mTORC1, is required for normal neuron migration during embryonic brain development, and plays a role in neuronal cell death.
The human DDIT4 gene encodes a protein found in the mitochondrion and cytosol, and belongs to the DDIT4 family. NCBI Gene annotation predicts that it enables 14-3-3 protein binding and describes its involvement in negative regulation of TOR signalling and the response to hypoxia. The protein is known by several names, including REDD-1, REDD1, RTP801 and Dig2, and the gene was previously named DNA-damage-inducible transcript 4. Mouse and rat both carry a Ddit4 ortholog, and a related gene, DDIT4L, is also recognised.
DDIT4 acts through AKT1, the TSC1-TSC2 complex and RHEB to inhibit mTORC1, making it a useful readout of growth-control pathways.
DDIT4 contributes to responses to cellular energy levels, hypoxia and DNA damage, with hypoxia-driven mTORC1 inhibition varying by cell type.
DDIT4 regulates p53/TP53-mediated apoptosis after DNA damage through its effect on mTORC1 activity.
DDIT4 affects neuron migration, NGF-mediated differentiation and neuronal cell death, and is required for mTORC1-mediated defence against viral replication.
DDIT4 inhibits mTORC1 and so regulates cell growth, proliferation and survival. It acts via AKT1, the TSC1-TSC2 complex and RHEB, and contributes to responses to energy status, hypoxia and DNA damage, including p53/TP53-mediated apoptosis.
DDIT4 is also called REDD-1, REDD1, RTP801 and Dig2, with FLJ20500 as a further alias. The HGNC name is DNA damage inducible transcript 4, and the earlier form was DNA-damage-inducible transcript 4. UniProt lists the protein as DNA damage-inducible transcript 4 protein.
Yes. Mouse and rat each have a Ddit4 ortholog, and the protein belongs to the DDIT4 family. Its role in hypoxia is cell-type dependent, so findings may differ between tissues. Check the datasheet of any product for its validated reactivity.
DDIT4L and DDIT3, related DNA damage-inducible genes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NX09; product specifications from Assay Genie datasheets.